Porcine Circovirus Vaccine, Type 2

Supplied By: Boehringer Ingelheim (162664)


SKU
075674


Unit of
Measure
100 Dose


Pack
Type
Vial


Case
Qty
12

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jul- 2025 Jun- 2025 May- 2025 Apr- 2025 Mar- 2025 Feb- 2025 Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024
{{purchaseHistoryItem}}


SKU
075674


Size
100 Dose

Case
Qty
12

Purchase History

Jul- 2025 {{productPurchaseHistory['075674'][0]}} Dec- 2024 {{productPurchaseHistory['075674'][0+7]}}
Jun- 2025 {{productPurchaseHistory['075674'][1]}} Nov- 2024 {{productPurchaseHistory['075674'][1+7]}}
May- 2025 {{productPurchaseHistory['075674'][2]}} Oct- 2024 {{productPurchaseHistory['075674'][2+7]}}
Apr- 2025 {{productPurchaseHistory['075674'][3]}} Sep- 2024 {{productPurchaseHistory['075674'][3+7]}}
Mar- 2025 {{productPurchaseHistory['075674'][4]}} Aug- 2024 {{productPurchaseHistory['075674'][4+7]}}
Feb- 2025 {{productPurchaseHistory['075674'][5]}} Jul- 2024 {{productPurchaseHistory['075674'][5+7]}}
Jan- 2025 {{productPurchaseHistory['075674'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

For vaccination of healthy pigs 3 weeks of age or older as an aid in prevention of lymphoid depletion, inflammation and colonization of lymphoid tissue, and as an aid in reduction of the magnitude of viremia associated with Porcine Circovirus Type 2 (PCV2). The onset of protection is two weeks prior to vaccination. The duration of immunity is at least four months.

Features & Benefits

  • Onset of immunity within two weeks of vaccination
  • At least four months duration of immunity
  • Single dose, 1 mL
  • Low risk of adverse reactions and stress on pigs due to one dose administration
  • PQA Plus friendly
  • Contains ImpranFLEX, an effective, aqueous-based (non-oil) polymer adjuvant
  • Flexible vaccination scheduling
  • Reduces PCV2 viremia